ER Stress Cooperates with Hypernutrition to Trigger TNF-Dependent Spontaneous HCC Development

Steatohepatitis: A tale of two “hits”?

Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285 · see citing works

Hepatocellular Carcinoma

El-Serag, H. B. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1001683 · Cited by 3,529 · see citing works

Endoplasmic reticulum stress and the inflammatory basis of metabolic disease

Hotamisligil, G. S. (2010) · Cell · doi:10.1016/j.cell.2010.02.034 · Cited by 2,802 · see citing works

Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis

Tilg, H., & Moschen, A. R. (2010) · Hepatology · doi:10.1002/hep.24001 · Cited by 2,548 · see citing works

Chemical Chaperones Reduce ER Stress and Restore Glucose Homeostasis in a Mouse Model of Type 2 Diabetes

Özcan, U., Yilmaz, E., Özcan, L., Furuhashi, M., Vaillancourt, E., Smith, R. O., Görgün, C. Z., & Hotamisligil, G. S. (2006) · Science · doi:10.1126/science.1128294 · Cited by 2,413 · see citing works

Endoplasmic reticulum stress: cell life and death decisions

Xu, C. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26373 · Cited by 2,260 · see citing works

Human Fatty Liver Disease: Old Questions and New Insights

Cohen, J. C., Horton, J. D., & Hobbs, H. H. (2011) · Science · doi:10.1126/science.1204265 · Cited by 2,089 · see citing works

Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression

Park, E. J., Lee, J. H., Yu, G.-Y., He, G., Ali, S. R., Holzer, R. G., Österreicher, C. H., Takahashi, H., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2009.12.052 · Cited by 1,764 · see citing works

Protein Sensors for Membrane Sterols

Goldstein, J. L., DeBose‐Boyd, R. A., & Brown, M. S. (2006) · Cell · doi:10.1016/j.cell.2005.12.022 · Cited by 1,685 · see citing works

Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans

Anderson, E. J., Lustig, M. E., Boyle, K. E., Woodlief, T. L., Kane, D. A., Lin, C.-T., Price, J. W., Kang, L., Rabinovitch, P. S., Szeto, H. H., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37048 · Cited by 1,253 · see citing works

Endoplasmic reticulum stress in liver disease

Malhi, H., & Kaufman, R. J. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.11.005 · Cited by 1,178 · see citing works

IKKβ Couples Hepatocyte Death to Cytokine-Driven Compensatory Proliferation that Promotes Chemical Hepatocarcinogenesis

Maeda, S., Kamata, H., Luo, J., Leffert, H. L., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2005.04.014 · Cited by 1,165 · see citing works

Regulation of Hepatic Lipogenesis by the Transcription Factor XBP1

Lee, A., Scapa, E. F., Cohen, D. E., & Glimcher, L. H. (2008) · Science · doi:10.1126/science.1158042 · Cited by 978 · see citing works

Nonalcoholic Steatohepatitis: Definition and Pathology

Brunt, E. M. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-12925 · Cited by 915 · see citing works

GRP78 expression inhibits insulin and ER stress–induced SREBP-1c activation and reduces hepatic steatosis in mice

Kammoun, H. L., Chabanon, H., Hainault, I., Luquet, S., Magnan, C., Koike, T., Ferré, P., & Foufelle, F. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37007 · Cited by 732 · see citing works

Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells

Inami, Y., Waguri, S., Sakamoto, A., Kouno, T., Nakada, K., Hino, O., Watanabe, S., Ando, J., Iwadate, M., Yamamoto, M. P., et al. (2011) · The Journal of Cell Biology · doi:10.1083/jcb.201102031 · Cited by 603 · see citing works

Activation and Dysregulation of the Unfolded Protein Response in Nonalcoholic Fatty Liver Disease

Puri, P., Mirshahi, F., Cheung, O., Natarajan, R., Maher, J. W., Kellum, J. M., & Sanyal, A. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.10.039 · Cited by 596 · see citing works

UPR Pathways Combine to Prevent Hepatic Steatosis Caused by ER Stress-Mediated Suppression of Transcriptional Master Regulators

Rutkowski, D. T., Wu, J., Back, S.-H., Callaghan, M. U., Ferris, S. P., Iqbal, J., Clark, R. L., Miao, H. Z., Hassler, J. R., Fornek, J. L., et al. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.10.015 · Cited by 580 · see citing works

Metabolic Factors and Risk of Hepatocellular Carcinoma by Chronic Hepatitis B/C Infection: A Follow-up Study in Taiwan

Chen, C., Yang, H., Yang, W., Liu, C., Chen, P., You, S., Wang, L., Sun, C., Lu, S., Chen, D., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.073 · Cited by 544 · see citing works

Hepatocyte Necrosis Induced by Oxidative Stress and IL-1α Release Mediate Carcinogen-Induced Compensatory Proliferation and Liver Tumorigenesis

Sakurai, T., He, G., Matsuzawa, A., Yu, G.-Y., Maeda, S., Hardiman, G., & Karin, M. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.06.016 · Cited by 487 · see citing works

Identification of Liver Cancer Progenitors Whose Malignant Progression Depends on Autocrine IL-6 Signaling

He, G., Dhar, D., Nakagawa, H., Font-Burgada, J., Ogata, H., Jiang, Y., Shalapour, S., Seki, E., Yost, S. E., Jepsen, K., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.031 · Cited by 474 · see citing works

NASH is an Infl ammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications

Farrell, G. C., Rooyen, D. M. V., Gan, L. T., & Chitturi, S. (2012) · Gut and Liver · doi:10.5009/gnl.2012.6.2.149 · Cited by 400 · see citing works

Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene

Sandgren, E. P., Palmiter, R. D., Heckel, J. L., Daugherty, C. C., Brinster, R. L., & Degen, J. L. (1991) · Cell · doi:10.1016/0092-8674(91)90615-6 · Cited by 392 · see citing works

A Lymphotoxin-Driven Pathway to Hepatocellular Carcinoma

Haybaeck, J., Zeller, N., Wolf, M. J., Weber, A., Wagner, U., Kurrer, M. O., Bremer, J., Iezzi, G., Graf, R., Clavien, P., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.08.021 · Cited by 381 · see citing works

Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents

Ota, T., Gayet, C., & Ginsberg, H. N. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32752 · Cited by 376 · see citing works

Maintenance of metabolic homeostasis by Sestrin2 and Sestrin3

Lee, J. H., Budanov, A. V., Talukdar, S., Park, E. J., Park, H. L., Park, H.-W., Bandyopadhyay, G., Li, N., Aghajan, M., Jang, I., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.08.004 · Cited by 295 · see citing works

Saturated Fatty Acids Induce c-Src Clustering within Membrane Subdomains, Leading to JNK Activation

Holzer, R. G., Park, E., Li, N., Tran, H., Chen, M. F., Choi, C., Solinas, G., & Karin, M. (2011) · Cell · doi:10.1016/j.cell.2011.08.034 · Cited by 284 · see citing works

Silencing of Lipid Metabolism Genes through IRE1α-Mediated mRNA Decay Lowers Plasma Lipids in Mice

So, J., Hur, K. Y., Tarrio, M. L., Ruda, V. M., Frank-Kamenetsky, M. D., Fitzgerald, K. J., Koteliansky, V., Lichtman, A. H., Iwawaki, T., Glimcher, L. H., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.09.004 · Cited by 280 · see citing works

Hepatocellular ballooning in NASH

Caldwell, S. H., Ikura, Y., Dias, D., Isomoto, K., Yabu, A., Moskaluk, C. A., Pramoonjago, P., Simmons, W., Scruggs, H., Rosenbaum, N., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.04.031 · Cited by 244 · see citing works

The steatohepatitic variant of hepatocellular carcinoma and its association with underlying steatohepatitis

Salomao, M. A., Remotti, H. E., VAUGHAN, R. D., Siegel, A. B., Lefkowitch, J. H., & Moreira, R. K. (2011) · Human Pathology · doi:10.1016/j.humpath.2011.07.005 · Cited by 180 · see citing works

Hepatocyte Transplantation into Diseased Mouse Liver

Weglarz, T. C., Degen, J. L., & Sandgren, E. P. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64835-3 · Cited by 149 · see citing works

Endoplasmic reticulum stress response in cancer: molecular mechanism and therapeutic potential.

Wang, G., Yang, Z. Q., & Zhang, K. (2010) · PubMed · Cited by 147 · see citing works

Obesity and Mortality

Calle, E. E., Teras, L. R., & Thun, M. J. (2005) · New England Journal of Medicine · doi:10.1056/nejm200511173532020 · Cited by 124 · see citing works

The Stress-Regulated Transcription Factor CHOP Promotes Hepatic Inflammatory Gene Expression, Fibrosis, and Oncogenesis

DeZwaan-McCabe, D., Riordan, J. D., Arensdorf, A. M., Icardi, M. S., Dupuy, A. J., & Rutkowski, D. T. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003937 · Cited by 84 · see citing works

Hepatic autophagy mediates endoplasmic reticulum stress–induced degradation of misfolded apolipoprotein B

Qiu, W., Zhang, J., Dekker, M. J., Wang, H., Huang, J., Brumell, J. H., & Adeli, K. (2011) · Hepatology · doi:10.1002/hep.24269 · Cited by 66 · see citing works

Stress Signaling in the Methionine-Choline–Deficient Model of Murine Fatty Liver Disease

Soon, R. K., Yan, J. S., Grenert, J. P., & Maher, J. J. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.07.046 · Cited by 56 · see citing works

Obesity, Inflammatory Signaling, and Hepatocellular Carcinoma—An Enlarging Link

Toffanin, S., Friedman, S. L., & Llovet, J. M. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.018 · Cited by 53 · see citing works

Adalimumab Could Suppress the Activity of Non Alcoholic Steatohepatitis (NASH)

Schramm, C., Schneider, A. R. J., Marx, A., & Lohse, A. (2008) · Zeitschrift für Gastroenterologie · doi:10.1055/s-2008-1027411 · Cited by 48 · see citing works

Hepatocellular carcinoma

Llovet, J. M., Kelley, R. K., Villanueva, A., Singal, A. G., Pikarsky, E., Roayaie, S., Lencioni, R., Koike, K., Zucman-Rossi, J., & Finn, R. S. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00240-3 · Cited by 7,055 · see citing works

Mechanisms of NAFLD development and therapeutic strategies

Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M., & Sanyal, A. J. (2018) · Nature Medicine · doi:10.1038/s41591-018-0104-9 · Cited by 4,354 · see citing works

NF-κB, inflammation, immunity and cancer: coming of age

Taniguchi, K., & Karin, M. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.142 · Cited by 2,679 · see citing works

Inflammation in obesity, diabetes, and related disorders

Rohm, T. V., Meier, D. T., Olefsky, J. M., & Donath, M. Y. (2022) · Immunity · doi:10.1016/j.immuni.2021.12.013 · Cited by 2,066 · see citing works

Mechanisms and disease consequences of nonalcoholic fatty liver disease

Loomba, R., Friedman, S. L., & Shulman, G. I. (2021) · Cell · doi:10.1016/j.cell.2021.04.015 · Cited by 2,002 · see citing works

Protein misfolding in the endoplasmic reticulum as a conduit to human disease

Wang, M., & Kaufman, R. J. (2016) · Nature · doi:10.1038/nature17041 · Cited by 1,630 · see citing works

From NASH to HCC: current concepts and future challenges

Anstee, Q. M., Reeves, H. L., Kotsiliti, E., Govaere, O., & Heikenwalder, M. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0145-7 · Cited by 1,392 · see citing works

NASH limits anti-tumour surveillance in immunotherapy-treated HCC

Pfister, D., Núñez, N. G., Pinyol, R., Govaere, O., Pinter, M., Szydlowska, M., Gupta, R., Qiu, M., Deczkowska, A., Weiner, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03362-0 · Cited by 1,294 · see citing works

The immunology of hepatocellular carcinoma

Ringelhan, M., Pfister, D., O’Connor, T., Pikarsky, E., & Heikenwalder, M. (2018) · Nature Immunology · doi:10.1038/s41590-018-0044-z · Cited by 1,076 · see citing works

Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease.

Lebeaupin, C., Vallée, D., Hazari, Y., Hetz, C., Chevet, É., & Bailly-maitre, B. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.06.008 · Cited by 835 · see citing works

Tumorigenic and Immunosuppressive Effects of Endoplasmic Reticulum Stress in Cancer

Cubillos‐Ruiz, J. R., Bettigole, S. E., & Glimcher, L. H. (2017) · Cell · doi:10.1016/j.cell.2016.12.004 · Cited by 892 · see citing works

Reparative inflammation takes charge of tissue regeneration

Karin, M., & Clevers, H. (2016) · Nature · doi:10.1038/nature17039 · Cited by 767 · see citing works

NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis

Ma, C., Kesarwala, A. H., Eggert, T., Medina-Echeverz, J., Kleiner, D. E., Jin, P., Stroncek, D. F., Terabe, M., Kapoor, V., ElGindi, M., et al. (2016) · Nature · doi:10.1038/nature16969 · Cited by 766 · see citing works

Metabolic Activation of Intrahepatic CD8+ T Cells and NKT Cells Causes Nonalcoholic Steatohepatitis and Liver Cancer via Cross-Talk with Hepatocytes

Wolf, M. J., Adili, A., Piotrowitz, K., Abdullah, Z., Boege, Y., Stemmer, K., Ringelhan, M., Simonavicius, N., Egger, M., Wohlleber, D., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.003 · Cited by 678 · see citing works

Macrophages in health and disease

Park, M. D., Silvin, A., Ginhoux, F., & Merad, M. (2022) · Cell · doi:10.1016/j.cell.2022.10.007 · Cited by 644 · see citing works

Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine

Fujiwara, N., Friedman, S. L., Goossens, N., & Hoshida, Y. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.09.016 · Cited by 659 · see citing works

Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

Massarweh, N. N., & El‐Serag, H. B. (2017) · Cancer Control · doi:10.1177/1073274817729245 · Cited by 637 · see citing works

Immune cell-mediated features of non-alcoholic steatohepatitis

Huby, T., & Gautier, E. L. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00639-3 · Cited by 573 · see citing works

Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity

Shalapour, S., Lin, X.-J., Bastian, I. N., Brain, J., Burt, A. D., Aksenov, A. A., Vrbanac, A. F., Li, W., Perkins, A., Matsutani, T., et al. (2017) · Nature · doi:10.1038/nature24302 · Cited by 589 · see citing works

Apoptosis and necroptosis in the liver: a matter of life and death

Schwabe, R. F., & Luedde, T. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0065-y · Cited by 582 · see citing works

Oxidative Stress in Liver Pathophysiology and Disease

Allameh, A., Niayesh‐Mehr, R., Aliarab, A., Sebastiani, G., & Pantopoulos, K. (2023) · Antioxidants · doi:10.3390/antiox12091653 · Cited by 565 · see citing works

Anti-Cancer Natural Products and Their Bioactive Compounds Inducing ER Stress-Mediated Apoptosis: A Review

Kim, C., & Kim, B. (2018) · Nutrients · doi:10.3390/nu10081021 · Cited by 496 · see citing works

Hybrid Periportal Hepatocytes Regenerate the Injured Liver without Giving Rise to Cancer

Font-Burgada, J., Shalapour, S., Ramaswamy, S., Hsueh, B., Rossell, D., Umemura, A., Taniguchi, K., Nakagawa, H., Valasek, M. A., Ye, L., et al. (2015) · Cell · doi:10.1016/j.cell.2015.07.026 · Cited by 486 · see citing works

p62, upregulated during preneoplasia, induces hepatocellular carcinogenesis by maintaining survival of stressed HCC-initiating cells

Umemura, A., He, F., Taniguchi, K., Nakagawa, H., Yamachika, S., Font-Burgada, J., Zhong, Z., Subramaniam, S., Raghunandan, S., Duran, A., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.04.006 · Cited by 438 · see citing works

Inflammation and Liver Cancer: Molecular Mechanisms and Therapeutic Targets

Yang, Y. M., Kim, S., & Seki, E. (2019) · Seminars in Liver Disease · doi:10.1055/s-0038-1676806 · Cited by 453 · see citing works

Metabolic Messengers: tumour necrosis factor

Sethi, J. K., & Hotamışlıgil, G. S. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00470-z · Cited by 426 · see citing works

Endoplasmic reticulum stress in liver diseases

Ajoolabady, A., Kaplowitz, N., Lebeaupin, C., Kroemer, G., Kaufman, R. J., Malhi, H., & Ren, J. T. (2022) · Hepatology · doi:10.1002/hep.32562 · Cited by 410 · see citing works

Obesity and cancer: inflammation bridges the two

Kolb, R. H., Sutterwala, F. S., & Zhang, W. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.07.005 · Cited by 411 · see citing works

ER stress induces NLRP3 inflammasome activation and hepatocyte death

Lebeaupin, C., Proïcs, E., de Bieville, C.-H. D., Rousseau, D., Bonnafous, S., Patouraux, S., Adam, G., Lavallard, V., Rovère, C., Thuc, O. L., et al. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.248 · Cited by 400 · see citing works

p62 in Cancer: Signaling Adaptor Beyond Autophagy

Moscat, J., Karin, M., & Díaz-Meco, M. T. (2016) · Cell · doi:10.1016/j.cell.2016.09.030 · Cited by 392 · see citing works

ATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT) to block stress-related ferroptosis

He, F., Zhang, P., Liu, J., Wang, R., Kaufman, R. J., Yaden, B. C., & Karin, M. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.03.016 · Cited by 399 · see citing works

Adaptive immunity: an emerging player in the progression of NAFLD

Sutti, S., & Albano, E. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0210-2 · Cited by 374 · see citing works

Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC

Grohmann, M., Wiede, F., Dodd, G. T., Gurzov, E. N., Ooi, G. J., Butt, T., Rasmiena, A. A., Kaur, S., Gulati, T., Goh, P. K., et al. (2018) · Cell · doi:10.1016/j.cell.2018.09.053 · Cited by 373 · see citing works

STAT3 Activation-Induced Fatty Acid Oxidation in CD8+ T Effector Cells Is Critical for Obesity-Promoted Breast Tumor Growth

Zhang, C.-Y., Yue, C., Herrmann, A., Song, J., Egelston, C., Wang, T., Zhang, Z.-F., Li, W.-Z., Lee, H., Aftabizadeh, M., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.10.013 · Cited by 345 · see citing works

Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment

Llovet, J. M., Willoughby, C. E., Singal, A. G., Greten, T. F., Heikenwälder, M., El-Serag, H. B., Finn, R. S., & Friedman, S. L. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00754-7 · Cited by 354 · see citing works

Targeting Inflammation in Cancer Prevention and Therapy

Todoric, J., Antonucci, L., & Karin, M. (2016) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-16-0209 · Cited by 367 · see citing works

Obesity and Cancer: The Oil that Feeds the Flame

Font-Burgada, J., Sun, B., & Karin, M. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.015 · Cited by 354 · see citing works

ER Stress Drives Lipogenesis and Steatohepatitis via Caspase-2 Activation of S1P

Kim, J. Y., Garcia-Carbonell, R., Yamachika, S., Zhao, P., Dhar, D., Loomba, R., Kaufman, R. J., Saltiel, A. R., & Karin, M. (2018) · Cell · doi:10.1016/j.cell.2018.08.020 · Cited by 333 · see citing works

Fructose stimulated de novo lipogenesis is promoted by inflammation

Todoric, J., Di Caro, G., Reibe, S., Henstridge, D. C., Green, C. R., Vrbanac, A., Ceteci, F., Conche, C., McNulty, R., Shalapour, S., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0261-2 · Cited by 328 · see citing works

Obesity-Induced TNFα and IL-6 Signaling: The Missing Link between Obesity and Inflammation—Driven Liver and Colorectal Cancers

Kern, L., Mittenbühler, M., Vesting, A., Ostermann, A., Wunderlich, C., & Wunderlich, F. (2018) · Cancers · doi:10.3390/cancers11010024 · Cited by 331 · see citing works

Role of nonresolving inflammation in hepatocellular carcinoma development and progression

Yu, L., Yan, L., & Wang, H. (2018) · npj Precision Oncology · doi:10.1038/s41698-018-0048-z · Cited by 302 · see citing works

Cell Death in Liver Diseases: A Review

Shojaie, L., Iorga, A., & Dara, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249682 · Cited by 299 · see citing works

Inflammation-Induced Tumorigenesis and Metastasis

Hibino, S., Kawazoe, T., Kasahara, H., Itoh, S., Ishimoto, T., Sakata‐Yanagimoto, M., & Taniguchi, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115421 · Cited by 303 · see citing works

Recent advances in hepatocellular carcinoma therapy

Dutta, R., & Mahato, R. I. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.010 · Cited by 281 · see citing works

Gastrointestinal Complications of Obesity

Camilleri, M., Malhi, H., & Acosta, A. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.12.052 · Cited by 269 · see citing works

Liver fibrosis: Pathophysiology and clinical implications

Berumen, J. A., Baglieri, J., Kisseleva, T., & Mekeel, K. L. (2020) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1499 · Cited by 262 · see citing works

Prolonged hypernutrition impairs TREM2-dependent efferocytosis to license chronic liver inflammation and NASH development

Wang, X., He, Q., Zhou, C., Xu, Y., Liu, D., Fujiwara, N., Kubota, N., Click, A., Henderson, P., Vancil, J., et al. (2023) · Immunity · doi:10.1016/j.immuni.2022.11.013 · Cited by 262 · see citing works

Preclinical Models for Studying NASH-Driven HCC: How Useful Are They?

Febbraio, M. A., Reibe, S., Shalapour, S., Ooi, G., Watt, M. J., & Karin, M. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.10.012 · Cited by 250 · see citing works

Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Lee, K., Wu, P.-S., & Lin, H. (2022) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0237 · Cited by 260 · see citing works

ER Stress Responses: An Emerging Modulator for Innate Immunity

Conza, G. D., & Ho, P. (2020) · Cells · doi:10.3390/cells9030695 · Cited by 247 · see citing works

Mouse models of hepatocellular carcinoma: an overview and highlights for immunotherapy research

Brown, Z. J., Heinrich, B., & Greten, T. F. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0033-6 · Cited by 246 · see citing works

Nrf2-p62 autophagy pathway and its response to oxidative stress in hepatocellular carcinoma

Bartolini, D., Dallaglio, K., Torquato, P., Piroddi, M., & Galli, F. (2017) · Translational research · doi:10.1016/j.trsl.2017.11.007 · Cited by 236 · see citing works

Pas de Deux: Control of Anti-tumor Immunity by Cancer-Associated Inflammation

Shalapour, S., & Karin, M. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.021 · Cited by 229 · see citing works

Transcription Factor C/EBP Homologous Protein in Health and Diseases

Yang, Y., Liu, L., Naik, I., Braunstein, Z., Zhong, J., & Ren, B. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01612 · Cited by 226 · see citing works

Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments

Peng, C. Y., Stewart, A. G., Woodman, O. L., Ritchie, R. H., & Qin, C. X. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.603926 · Cited by 225 · see citing works

CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity

Fujiwara, N., Nakagawa, H., Enooku, K., Kudo, Y., Hayata, Y., Nakatsuka, T., Tanaka, Y., Tateishi, R., Hikiba, Y., Misumi, K., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315193 · Cited by 221 · see citing works

The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling

Mohamed, E. T., Sierra, R. A., Trillo-Tinoco, J., Cao, Y. W., Innamarato, P., Payne, K. K., Pulido, Á. D. M., Mandula, J. K., Zhang, S., Thevenot, P., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.03.004 · Cited by 219 · see citing works

FBP1 loss disrupts liver metabolism and promotes tumorigenesis through a hepatic stellate cell senescence secretome

Li, F., Huangyang, P., Burrows, M., Guo, K., Riscal, R., Godfrey, J. T., Lee, K. E., Lin, N., Lee, P., Blair, I. A., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0511-2 · Cited by 211 · see citing works

A researcher’s guide to preclinical mouse NASH models

Gallage, S., Avila, J. E. B., Ramadori, P., Focaccia, E., Rahbari, M., Ali, A., Malek, N. P., Anstee, Q. M., & Heikenwälder, M. F. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00700-y · Cited by 198 · see citing works

Kupffer Cell-Derived Tnf Triggers Cholangiocellular Tumorigenesis through JNK due to Chronic Mitochondrial Dysfunction and ROS

Yuan, D.-T., Huang, S., Berger, E., Liu, L., Gross, N., Heinzmann, F., Ringelhan, M., Connor, T. O., Stadler, M., Meister, M., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.05.006 · Cited by 183 · see citing works

The immunobiology of hepatocellular carcinoma in humans and mice: Basic concepts and therapeutic implications

Hou, J., Zhang, H., Sun, B., & Karin, M. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.014 · Cited by 191 · see citing works

Metformin modulates innate immune-mediated inflammation and early progression of NAFLD-associated hepatocellular carcinoma in zebrafish

de Oliveira, S., Houseright, R. A., Graves, A. L., Golenberg, N., Korte, B. G., Miskolci, V., & Anna Huttenlocher, A. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.11.034 · Cited by 189 · see citing works

Endoplasmic reticulum stress and liver diseases

Liu, X., & Green, R. M. (2019) · Liver Research · doi:10.1016/j.livres.2019.01.002 · Cited by 183 · see citing works

Lipid Metabolic Reprogramming in Hepatocellular Carcinoma

Nakagawa, H., Hayata, Y., Kawamura, S., Yamada, T., Fujiwara, N., & Koike, K. (2018) · Cancers · doi:10.3390/cancers10110447 · Cited by 176 · see citing works

“Sweet death”: Fructose as a metabolic toxin that targets the gut-liver axis

Febbraio, M. A., & Karin, M. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.09.004 · Cited by 177 · see citing works

Current concepts of immune based treatments for patients with HCC: from basic science to novel treatment approaches

Greten, T., Wang, X.-W., & Korangy, F. (2015) · Gut · doi:10.1136/gutjnl-2014-307990 · Cited by 181 · see citing works

ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression

Cao, Y., Trillo-Tinoco, J., Sierra, R. A., Anadon, C., Dai, W., Mohamed, E., Cen, L., Costich, T. L., Magliocco, A., Marchion, D., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09263-1 · Cited by 161 · see citing works

Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)

Wang, S., & Friedman, S. L. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adi0759 · Cited by 158 · see citing works

Lipid Metabolism in Development and Progression of Hepatocellular Carcinoma

Sangineto, M., Villani, R., Cavallone, F., Romano, A. D., Loizzi, D., & Serviddio, G. (2020) · Cancers · doi:10.3390/cancers12061419 · Cited by 152 · see citing works

TNF-Receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD mice

Wandrer, F., Liebig, S., Marhenke, S., Vogel, A., John, K., Manns, M. P., Teufel, A., Itzel, T., Longerich, T., Maier, O., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2411-6 · Cited by 153 · see citing works

Endoplasmic Reticulum Stress in Metabolic Liver Diseases and Hepatic Fibrosis

Maiers, J. L., & Malhi, H. (2019) · Seminars in Liver Disease · doi:10.1055/s-0039-1681032 · Cited by 151 · see citing works

O-GlcNAc transferase promotes fatty liver-associated liver cancer through inducing palmitic acid and activating endoplasmic reticulum stress

Xu, W., Zhang, X., Wu, J., Fu, L., Liu, K., Liu, D., Chen, G. G., Lai, P. B. S., Wong, N., & Yu, J. Q. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.017 · Cited by 148 · see citing works

Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD

Reeves, H. L., Zaki, M. Y. W., & Day, C. P. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4085-6 · Cited by 147 · see citing works

Clinical and histologic features of adults with alpha-1 antitrypsin deficiency in a non-cirrhotic cohort

Clark, V., Marek, G. W., Liu, C., Collinsworth, A., Shuster, J. J., Kurtz, T. L., Nolte, J. L., & Brantly, M. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.08.005 · Cited by 142 · see citing works

Role of immune responses in the development of NAFLD-associated liver cancer and prospects for therapeutic modulation

Yahoo, N., Dudek, M., Knolle, P. A., & Heikenwälder, M. F. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.02.033 · Cited by 145 · see citing works

SREBP Regulation of Lipid Metabolism in Liver Disease, and Therapeutic Strategies

Li, N., Li, X., Ding, Y., Liu, X., Diggle, K., Kisseleva, T., & Brenner, D. A. (2023) · Biomedicines · doi:10.3390/biomedicines11123280 · Cited by 140 · see citing works

Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis

Rimini, M., Rimassa, L., Ueshima, K., Burgio, V., Shigeo, S., Tada, T., Suda, G., Yoo, C., Cheon, J., Pinato, D. J., et al. (2022) · ESMO Open · doi:10.1016/j.esmoop.2022.100591 · Cited by 121 · see citing works

Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC

Kim, H.-M., Lee, D. S., An, T. H., Park, H., Kim, W. K., Bae, K., & Oh, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094495 · Cited by 130 · see citing works

Puerariae Lobatae radix flavonoids and puerarin alleviate alcoholic liver injury in zebrafish by regulating alcohol and lipid metabolism

Liu, Y.-S., Yuan, M.-H., Zhang, C., Liu, H., Liu, J., Wei, A., Ye, Q., Zeng, B., Li, M.-F., Guo, Y., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111121 · Cited by 123 · see citing works

Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver disease

Fujiwara, N., Kubota, N., Crouchet, É., Koneru, B., Marquez, C. A., Jajoriya, A. K., Panda, G., Qian, T., Zhu, S., Goossens, N., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abo4474 · Cited by 124 · see citing works

Early Hepatic Lesions Display Immature Tertiary Lymphoid Structures and Show Elevated Expression of Immune Inhibitory and Immunosuppressive Molecules

Meylan, M., Petitprez, F., Lacroix, L., Tommaso, L. D., Roncalli, M. G., Bougoüin, A., Laurent, A., Amaddeo, G., Sommacale, D., Regnault, H., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-2929 · Cited by 121 · see citing works

Spontaneous Hepatocellular Carcinoma after the Combined Deletion of Akt Isoforms

Wang, Q., Yu, W.-N., Chen, X., Peng, X.-D., Jeon, S., Birnbaum, M. J., Guzman, G., & Hay, N. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.02.008 · Cited by 120 · see citing works

Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy

Lian, X., Yang, K., Li, R., Li, M., Zuo, J., Zheng, B., Wang, W., Wang, P., & Zhou, S. (2022) · Molecular Cancer · doi:10.1186/s12943-021-01486-5 · Cited by 120 · see citing works

Inhibiting SCAP/SREBP exacerbates liver injury and carcinogenesis in murine nonalcoholic steatohepatitis

Kawamura, S., Matsushita, Y., Kurosaki, S., Tange, M., Fujiwara, N., Hayata, Y., Hayakawa, Y., Suzuki, N., Hata, M., Tsuboi, M., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci151895 · Cited by 115 · see citing works

Protein phase separation and its role in tumorigenesis

Jiang, S., Fagman, J. B., Chen, C., Alberti, S., & Liu, B. (2020) · eLife · doi:10.7554/elife.60264 · Cited by 115 · see citing works

Cancer stemness in hepatocellular carcinoma: mechanisms and translational potential

Tsui, Y., Chan, L., & Ng, I. O. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0823-9 · Cited by 115 · see citing works

Maladaptive regeneration - the reawakening of developmental pathways in NASH and fibrosis

Zhu, C., Tabas, I., Schwabe, R. F., & Pajvani, U. B. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00365-6 · Cited by 112 · see citing works

p62/SQSTM1- Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer

Taniguchi, K., Yamachika, S., He, F., & Karin, M. (2016) · FEBS Letters · doi:10.1002/1873-3468.12301 · Cited by 102 · see citing works

Control of immune cell function by the unfolded protein response

Conza, G. D., Ho, P., Cubillos‐Ruiz, J. R., & Huang, S. C. (2023) · Nature reviews. Immunology · doi:10.1038/s41577-023-00838-0 · Cited by 112 · see citing works

Endoplasmic Reticulum Stress Promotes the Expression of TNF-α in THP-1 Cells by Mechanisms Involving ROS/CHOP/HIF-1α and MAPK/NF-κB Pathways

Akhter, N., Wilson, A., Arefanian, H., Thomas, R., Kochumon, S., Al‐Rashed, F., Abu‐Farha, M., Madhoun, A. S. A., Al‐Mulla, F., Ahmad, R., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015186 · Cited by 112 · see citing works

Altered serum acylcarnitine profile is associated with the status of nonalcoholic fatty liver disease (NAFLD) and NAFLD-related hepatocellular carcinoma

Enooku, K., Nakagawa, H., Fujiwara, N., Kondo, M., Minami, T., Hoshida, Y., Shibahara, J., Tateishi, R., & Koike, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-47216-2 · Cited by 110 · see citing works

Cellular Mechanisms of Endoplasmic Reticulum Stress Signaling in Health and Disease. 3. Orchestrating the unfolded protein response in oncogenesis: an update

Manié, S. N., Lebeau, J., & Chevet, É. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00292.2014 · Cited by 105 · see citing works

Regulating metabolic inflammation by nutritional modulation

Charles‐Messance, H., Mitchelson, K. A. J., Castro, E. D. M., Sheedy, F. J., & Roche, H. M. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.08.013 · Cited by 113 · see citing works

Nidogen 1‐Enriched Extracellular Vesicles Facilitate Extrahepatic Metastasis of Liver Cancer by Activating Pulmonary Fibroblasts to Secrete Tumor Necrosis Factor Receptor 1

Mao, X., Tey, S. K., Yeung, C. L. S., Kwong, E. M. L., Fung, Y. M. E., Chung, C. Y., Mak, L., Wong, D. K.-H., Yuen, M., Ho, J., et al. (2020) · Advanced Science · doi:10.1002/advs.202002157 · Cited by 103 · see citing works

STARD1 promotes NASH-driven HCC by sustaining the generation of bile acids through the alternative mitochondrial pathway

de la Rosa, L. C., García‐Ruiz, C., Vallejo, C., Baulies, A., Núñez, S., Monte, M. J., Marı́n, J. J. G., Baila-Rueda, L., Cenarro, A., Civeira, F., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.01.028 · Cited by 101 · see citing works

Phenotypic assays identify azoramide as a small-molecule modulator of the unfolded protein response with antidiabetic activity

Fu, S., Yalçın, A., Lee, G. Y., Li, P., Fan, J., Arruda, A. P., Pers, B. M., Yilmaz, M., Eguchi, K., & Hotamışlıgil, G. S. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa9134 · Cited by 97 · see citing works

Cytokine Regulation of Metastasis and Tumorigenicity

Yao, M., Brummer, G., Acevedo, D. S., & Cheng, N. (2016) · Advances in cancer research · doi:10.1016/bs.acr.2016.05.005 · Cited by 96 · see citing works

Liver macrophages and inflammation in physiology and physiopathology of non‐alcoholic fatty liver disease

Thibaut, R., Gage, M., Pineda‐Torra, I., Chabrier, G., Venteclef, N., & Alzaïd, F. (2021) · FEBS Journal · doi:10.1111/febs.15877 · Cited by 95 · see citing works

Dihydroartemisinin triggers ferroptosis in primary liver cancer cells by promoting and unfolded protein response‑induced upregulation of CHAC1 expression

Wang, Z., Li, M., Liu, Y., Qiao, Z., Bai, T., Yang, L., & Liu, B. (2021) · Oncology Reports · doi:10.3892/or.2021.8191 · Cited by 95 · see citing works

Caffeine reduces hepatic lipid accumulation through regulation of lipogenesis and ER stress in zebrafish larvae

Zheng, X., Dai, W., Chen, X., Wang, K., Zhang, W., Liu, L., & Hou, J. (2015) · Journal of Biomedical Science · doi:10.1186/s12929-015-0206-3 · Cited by 94 · see citing works

Abstract PL03-03: ER stress and TNF signaling control the progression from simple steatosis to non-alcoholic steatohepatitis (NASH)

Karin, M. (2015) · Cancer Prevention Research · doi:10.1158/1940-6215.prev-14-pl03-03

Therapeutic blockade of ER stress and inflammation prevents NASH and progression to HCC

Boslem, E., Reibe, S., Carlessi, R., Smeuninx, B., Tegegne, S., Egan, C. L., McLennan, E., Terry, L. V., Nobis, M., Mu, A., et al. (2023) · Science Advances · doi:10.1126/sciadv.adh0831 · Cited by 39 · see citing works

Role of Inflammation in Control of Hepatic Lipid Metabolism—New Insights to the Pathogenesis of NASH

Karin, M. (2019) · The FASEB Journal · doi:10.1096/fasebj.2019.33.1_supplement.218.3

Therapeutic Blockade of ER Stress and Inflammation Prevents High Fat Diet-Induced NASH and Progression to Hepatocellular CarcinomaPreprint

Boslem, E., Riebe, S., Smeuninx, B., Egan, C. L., Tegegne, S., McLennan, E. D., Nobis, M., Mu, A., Nowell, C. J., Horadagoda, N. U., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4001943

Endoplasmic Reticulum Stress Signaling and the Pathogenesis of Hepatocarcinoma

Wei, J., & Fang, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041799 · Cited by 69 · see citing works